Remantadin®
Remantadin®
Active substance:Rimantadini hydrochloridum
Indications: Therapy of influenza and prevention thereof, prevention of tick-borne encephalitis
Dose and quantity: 50 mg N20
Pharmaceutical form: Tablets
Product ATC Code: J05AC02
Product Description
Antiviral agent – amantadine derivative.
Remantadin® is effective against influenza viruses of type A, as well as has an anti – toxic effect in cases of intoxication caused by influenza virus of type B. Remantadin® inhibits the viral replication cycle in early phases, possibly, by delaying the development of a viral capsid. Remantadin® is effective against flaviviruses caused by tick – borne encephalitis.
Therapeutic indications:
- Early treatment of influenza virus infection in adults and children over 7 years of age
- Prevention during influenza epidemic for adults and children from the age of 7 years old
Instructions